Compagnie Lebon operates within the Investors sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Compagnie Lebon with three other
financial institutions in Europe:
DeA Capital S.p.A.
sales of 76.59 million Euros [US$90.75 million]
MedCap AB (publ)
(757.10 million Swedish Kronor [US$86.27 million]
of which 57%
was Medical Technology), and
Deutsche Beteiligungs AG
based in GERMANY
(82.16 million Euros [US$97.35 million]
of which 60%
was Private Equity Investments).
During the year ended December of 2019, sales at
Compagnie Lebon were 84.61 million Euro (US$100.25 million).
increase of 42.4%
versus 2018, when the company's sales were 59.41 million Euro.
The sales level in 2019 was fairly close to the level five years ago: in 2014, Compagnie Lebon had sales
of 88.71 million Euro.
Sales of Financial Sector saw an increase
that was more than double the company's growth rate: sales were up
7,718.6% in 2019, from
70,000.00 Euro to 5.47 million Euro.
Compagnie Lebon also saw significant increases in sales in
Property-Real Estate (up 106.2% to 8.30 million Euro)
Not all segments of Compagnie Lebon experienced an increase in sales in 2019:
sales of Holding and Other fell 78.7% to 818,000.00 Euro.
Compagnie Lebon also experienced decreases in sales in
Hotel Sector (down 6.6% to 47.28 million Euro)